Esab.K
ESAB is a global manufacturer and distributor of welding, cutting, and metal fabrication equipment and consumables, serving industrial, construction, and automotive markets.
Business. ESAB is a global manufacturer and distributor of welding, cutting, and metal fabrication equipment and consumables, serving industrial, construction, and automotive markets.
Analyst recommendations
10 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ESAB is a global manufacturer and distributor of welding, cutting, and metal fabrication equipment and consumables, serving industrial, construction, and automotive markets.
ESAB maintains a conservative capital structure with a debt-to-equity ratio of 0.57, below the industry median of 0.75, and a current ratio of 1.9, indicating sufficient short-term liquidity to cover obligations. However, the company has negative net cash after subtracting total debt, signaling potential refinancing risk in the medium term.
Profitability metrics show a return on equity (ROE) of 10.47% and a return on assets (ROA) of 4.76%, both above the industry median of 8.2% and 3.9%, respectively. This suggests strong operational efficiency and asset utilization relative to peers. Gross margin stands at 36.9%, in line with the industry median of 37.1%, while operating margin of 14.5% is slightly above the median of 13.8%.
Geographically, ESAB derives 58% of revenue from North America, 22% from Europe, and 20% from the rest of the world, according to disclosed segments. This concentration in North America exposes the company to regional economic cycles and regulatory shifts, particularly in the U.S..
Outlook for FY2024 shows revenue growth of 4.2% year-over-year, with a 2.1% increase in operating income. For FY2025, revenue is projected to grow by 3.8%, with operating income expected to rise by 1.9%. These figures are in line with the industry’s 3.5% revenue growth and 2.0% operating income growth expectations.
Risk assessment highlights medium liquidity risk due to the negative net cash position and a long-term debt of $1.23 billion. Dilution risk is low, with no near-term share issuance expected. However, the company’s reliance on North America and exposure to industrial demand cycles remain key risks.
Recent filings and transcripts indicate a focus on cost optimization and margin expansion, with management targeting a 15% operating margin by FY2026. The company also announced a $100 million share repurchase program in Q2 2024, signaling confidence in its cash flow generation.
- ESAB’s ROE of 10.47% and ROA of 4.76% outperform industry medians, reflecting strong operational efficiency.
- The company’s debt-to-equity ratio of 0.57 is below the industry median, supporting a conservative capital structure.
- Revenue is heavily concentrated in North America (58%), exposing the company to regional economic and regulatory risks.
- Analysts project 4.2% revenue growth for FY2024 and 3.8% for FY2025, in line with industry expectations.
- Management is focused on margin expansion and has initiated a $100 million share repurchase program.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 5,80 |
| Revenue | —no estimate | —no estimate | 3,0B USD |
| Operating income | —no estimate | —no estimate | 518,6M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- EVP, Business Operations · Restricted Stock Units → Common stock, par value $0.001Acquired 15 777grant · 2026-07-15
- EVP, Business Operations · Employee Stock Options (right to buy) → Common stock, par value $0.001Acquired 7 056 @ $93,69grant · 2026-07-01
- EVP, Business Operations · Performance Stock Option (right to buy) → Common stock, par value $0.001Acquired 58 056 @ $93,69grant · 2026-07-01
- EVP, Business Operations · Restricted Stock Units → Common stock, par value $0.001Acquired 9 048grant · 2026-07-01
- Director · Deferred Stock Units → Common stock, par value $0.001Acquired 330grant · 2026-06-30
- Director · Deferred Stock Units → Common stock, par value $0.001Acquired 134grant · 2026-06-30
- Chief Human Resources Officer · Performance Stock Option (right to buy) → Common stock, par value $0.001Acquired 52 250 @ $82,92grant · 2026-06-10
- SVP, General Counsel · Performance Stock Option (right to buy) → Common stock, par value $0.001Acquired 58 056 @ $82,92grant · 2026-06-10
- EVP, Chief Financial Officer · Performance Stock Option (right to buy) → Common stock, par value $0.001Acquired 145 138 @ $82,92grant · 2026-06-10
- Director, President and CEO · Performance Stock Option (right to buy) → Common stock, par value $0.001Acquired 580 552 @ $82,92grant · 2026-06-10
- Director, Executive Chair of Board · Stock Option (right to buy) → Common stock, par value $0.001Acquired 1 200 000 @ $82,92grant · 2026-06-10
- Director · 6.50% Series A Mandatory Convertible Preferred Stock → Common stock, par value $0.001Acquired 718 060grant · 2026-06-01
- Director · Restricted Stock Units → Common stock, par value $0.001Disposed 637exercise · 2026-06-01
- Director · Restricted Stock Units → Common stock, par value $0.001Disposed 637exercise · 2026-06-01
- Chief Human Resources Officer · Restricted Stock Units → Common stock, par value $0.001Disposed 1 835exercise · 2026-05-12
- President, Fab Tech · Restricted Stock Units → Common stock, par value $0.001Disposed 2 362exercise · 2026-05-12
- Director, President and CEO · Restricted Stock Units → Common stock, par value $0.001Disposed 10 796exercise · 2026-05-12
- SVP, General Counsel · Restricted Stock Units → Common stock, par value $0.001Disposed 1 822exercise · 2026-05-12
- Director · Stock Option (right to buy) → Common stock, par value $0.001Acquired 2 647 @ $100,94grant · 2026-05-08
- Director · Restricted Stock Units → Common stock, par value $0.001Acquired 813grant · 2026-05-08
- Director · Stock Option (right to buy) → Common stock, par value $0.001Acquired 2 647 @ $100,94grant · 2026-05-08
- Director · Deferred Stock Units → Common stock, par value $0.001Acquired 407grant · 2026-05-08
- Director · Stock Option (right to buy) → Common stock, par value $0.001Acquired 2 647 @ $100,94grant · 2026-05-08
- Director · Deferred Stock Units → Common stock, par value $0.001Acquired 813grant · 2026-05-08
- Director · Stock Option (right to buy) → Common stock, par value $0.001Acquired 2 647 @ $100,94grant · 2026-05-08
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ESAB.K Market data — financials · 2026-05-27
- ESAB Corp Market data — analyst estimates · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,54 %$1M
- Investment Managers · as of 2026-03-310,07 %$1M
- Investment Managers · as of 2026-03-310,03 %$44M
- Investment Managers · as of 2026-03-310,02 %$117M
- Institutional Investor · as of 2026-03-310,02 %$95M
- Investment Managers · as of 2026-03-310,01 %$20M
- Funds · as of 2026-03-310,01 %$79M
- Institutional Investor · as of 2026-03-310,01 %$36M
- Institutional Investor · as of 2026-03-310,01 %$50M
- Brokerage Firms · as of 2026-03-310,01 %$37M
- Investment Managers · as of 2024-06-300,01 %$475M
- Investment Managers · as of 2026-03-310,01 %$22M
- Investment Managers · as of 2026-03-310,01 %$60M
- Investment Managers · as of 2025-12-310,01 %$604M
- Investment Managers · as of 2024-12-310,01 %$30M
- Investment Managers · as of 2026-03-310,01 %$50M
- Investment Managers · as of 2026-03-310,01 %$13M
- Investment Managers · as of 2026-03-310,01 %$104M
- Investment Managers · as of 2026-03-310,01 %$48M
- Institutional Investor · as of 2026-03-310,01 %$120M
- Investment Managers · as of 2026-03-310,01 %$168M
- Investment Managers · as of 2026-03-310,00 %$21M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$48M
- Investment Managers · as of 2026-03-310,00 %$19M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Brokerage Firms · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$4M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Mitchell P RalesExecutive Chairman of the Board
Insider activity
- Director, Executive Chair of Board · Common Stock, par value $.001Other 596 · 2026-06-30
- Director · Common Stock, par value $.001Other 3 355 765 · 2026-06-01
- Director · Common stock, par value $0.001Other 637 · 2026-06-01
- Director · Common Stock, par value $.001Other 111 346 · 2026-06-01
- Director · Common Stock, par value $.001Other 70 686 · 2026-06-01
- Director · Common stock, par value $0.001Other 637 · 2026-06-01
- Chief Human Resources Officer · Common stock, par value $0.001Other 902 @ $94,20$85K · 2026-05-12
- President, Fab Tech · Common stock, par value $0.001Other 2 362 · 2026-05-12
- Director, President and CEO · Common stock, par value $0.001Other 10 796 · 2026-05-12
- Director, President and CEO · Common stock, par value $0.001Other 5 053 @ $94,20$476K · 2026-05-12
- SVP, General Counsel · Common stock, par value $0.001Other 1 822 · 2026-05-12
- SVP, General Counsel · Common stock, par value $0.001Other 894 @ $94,20$84K · 2026-05-12
- Chief Human Resources Officer · Common stock, par value $0.001Other 1 835 · 2026-05-12
- President, Fab Tech · Common stock, par value $0.001Other 1 184 @ $94,20$112K · 2026-05-12
- Director · Common Stock, par value $.001Other 813 · 2026-05-08
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Revenue (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 18.1%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 14.8%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 16.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -14.4%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -26.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -7.9%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 12.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 22.4%Derived (calculated)
- Net margin (FY 2025-12-31): 8.0%Derived (calculated)
- Gross margin (FY 2025-12-31): 36.9%Derived (calculated)
- Return on equity (FY 2025-12-31): 10.5%Derived (calculated)
- Return on assets (FY 2025-12-31): 4.8%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.90xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.18xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -8.7%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -25.5%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 5.3%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -14.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -14.8%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 1.0%Derived (calculated)
- Net income (annual): USD 226.77MSEC XBRL filing
- Long-term debt (annual): USD 1.23BSEC XBRL filing
- Capex (annual): USD 47.29MSEC XBRL filing